Wisconsin 2025 Regular Session Status: Introduced 3 R cosponsors

SB 83 — Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

Last action — Failed to pass pursuant to Senate Joint Resolution 1

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed Assembly
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced February 26, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Prognosis

Advancing 38% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • Introduced

    Current position in the legislative process.

  • 10 sponsors

    1 primary, 9 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (3 R).

  • Cleared a recorded vote

    Passed 2 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

An Act to create 49.45 (9o) of the statutes;

Bill Text

What changed in the latest version

34 added · 42 removed

Plain-language change summary

The latest version of Senate Bill 83 has changed its approach to managing prescriptions for antipsychotic drugs within the Medical Assistance program. Instead of completely prohibiting any kind of management controls for these prescribed drugs, the bill now specifically focuses on eliminating the requirement for prior authorization under certain circumstances, such as when a patient has previously been stabilized on a medication or has been continuously using it for at least 60 days. This change is important because it aims to make it easier for patients to access their necessary medications without unnecessary delays, improving their overall healthcare experience.

→
Previous
Latest
- 2026 LEGISLATURE LRBs0124/1 JPC:emw SENATE SUBSTITUTE AMENDMENT 2, TO SENATE BILL 83 October 3, 2025 - Offered by Senator AMES .
- 2026 LEGISLATURE LRB-0646/1 JPC:emw SENATE BILL 83 February 26, 2025 - Introduced by Senators J AMES, C ABRAL-G UEVARA and W ANGGAARD , cosponsored by Representatives NOVAK , G UNDRUM , B.
JACOBSON , MURSAU , SORTWELL , TEFFEN and TITTL.
Referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families.
prior authorization for antipsychotic drugs under the Medical Assistance program.
utilization management controls for antipsychotic prescription drugs under the Medical Assistance program.
Analysis by the Legislative Reference Bureau This bill prohibits the Department of Health Services from requiring prior authorization for a covered antipsychotic drug for a Medical Assistance recipient who is at least 18 years of age under certain circumstances, including 1) if the antipsychotic drug was previously approved for the recipient at a different dosage;
Analysis by the Legislative Reference Bureau This bill prohibits the Department of Health Services from imposing any utilization management controls for prescription drugs under the Medical Assistance program that are approved by the federal Food and Drug Administration and are classified as antipsychotic.
2) if initial prior authorization for the antipsychotic drug expires for the recipient, and at the time of expiration, the recipient has taken the antipsychotic drug continuously for at least 60 days;
Utilization management controls are formal techniques used by a health carrier or prescription drug utilization management entity that are designed to evaluate prescription drug medical necessity, appropriateness, efficacy, or efficiency.
and 3) if the recipient was recently discharged from an inpatient hospital, and as an inpatient, the recipient was stabilized on the antipsychotic drug.
For further information see the state fiscal estimate, which will be printed as an appendix to this bill.
S ECTION 1.
- 2026 Legislature - 2 - LRB-0646/1 JPC:emw SENATE BILL 83 SECTION 1 S ECTION 1.
- 2026 Legislature - 2 - LRBs0124/1 JPC:emw SECTION 1 49.45 (9o) P RIOR AUTHORIZATION FOR ANTIPSYCHOTIC DRUGS .
49.45 (9o) U TILIZATION MANAGEMENT CONTROLS FOR ANTIPSYCHOTIC PRESCRIPTION DRUGS.
(a) In this subsection, Xantipsychotic drugY means a covered prescription drug that is approved by the federal food and drug administration and that is classified as an antipsychotic.
(a) In this subsection:
(b) The department may not require prior authorization for an antipsychotic drug under any of the following circumstances for a Medical Assistance recipient who is at least 18 years of age:
The antipsychotic drug was previously approved for the recipient at a different dosage.
“Prescription drug” has the meaning given in s.
450.01 (20).
The recipient was newly enrolled in the Medical Assistance program within the past 30 days, and the recipient was taking the antipsychotic drug continuously for at least 30 days at the time of enrollment.
“Utilization management controls” means a set of formal techniques used by a health carrier or prescription drug utilization management entity that are designed to evaluate prescription drug medical necessity, appropriateness, efficacy, or efficiency, including prior authorization and step therapy protocols.
3.
(b) The department may not impose utilization management controls for any prescription drug that is approved by the federal food and drug administration and is classified as an antipsychotic.
Initial prior authorization for the antipsychotic drug expires for the recipient, and at the time of expiration, the recipient has taken the antipsychotic drug continuously for at least 60 days.
(END)
4.
The recipient was recently discharged from an inpatient hospital, and as an inpatient, the recipient was stabilized on the antipsychotic drug.
(c) 1.
Nothing in this subsection otherwise restricts the department[s authority to require prior authorization as provided under federal law.
2.
Nothing in this subsection may be interpreted to conflict with 42 USC 1396a (oo).
(END )
View plain text versions (2)

Action History

  1. Failed to pass pursuant to Senate Joint Resolution 1

  2. Available for scheduling

  3. Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2

  4. Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2

  5. Executive action taken

  6. Public hearing held

  7. Senate Substitute Amendment 2 offered by Senator James

  8. Representative Subeck added as a cosponsor

  9. Senate Substitute Amendment 1 offered by Senator James

  10. Fiscal estimate received

  11. Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families

  12. Introduced by Senators James, Cabral-Guevara and Wanggaard; cosponsored by Representatives Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen and Tittl

Sponsors

  • Novak · Cosponsor
  • Gundrum · Cosponsor
  • B. Jacobson · Cosponsor
  • Mursau · Cosponsor
  • Sortwell · Cosponsor
  • Steffen · Cosponsor
  • Tittl · Cosponsor
  • Jesse James · Primary
  • Rachael Cabral-Guevara · Cosponsor
  • Van Wanggaard · Cosponsor

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 122 not signed on

Sponsors (1)

Co-sponsors (9)

Not signed on (122)

122 members have not signed on to this bill.

Show all 122 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 83 do?
An Act to create 49.45 (9o) of the statutes;
Who sponsors SB 83?
SB 83 is sponsored by Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen, Tittl, James, Jesse (Republican), Cabral-Guevara, Rachael (Republican), and Wanggaard, Van (Republican).
What is the current status of SB 83?
This bill has been introduced in the Senate. Introduced February 26, 2025. It must pass committee before a floor vote.
Where can I track SB 83?
Track SB 83 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 83

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of SB 83

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →